[1]
G. P. Anzola, “No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort”, Ital J Med, vol. 14, no. 3, pp. 162-166, Sep. 2020.